ANRS Emerging infectious diseases
9:15 a.m.
Welcome reception (coffee)
10:00 a.m.
Introduction
• Didier LEPELLETIER, Director general of Health, ministry for Health, Families, Autonomy and Disabled Persons, France
• Jean-Luc MOULLET, Director general of Research and Innovation, ministry for Higher Education, Research and Space, France
• Yazdan YAZDANPANAH, Director of ANRS Emerging infectious diseases, France
• Jean-Luc MOULLET, Director general of Research and Innovation, ministry for Higher Education, Research and Space, France
• Yazdan YAZDANPANAH, Director of ANRS Emerging infectious diseases, France
10:30 a.m.
Keynote Lectures
The African Medicines Agency : driving regulatory innovation to shape the future of biomedical research and access in Africa
• Delese Mimi DARKO, African Medicines Agency, Kigali, Rwanda
• Delese Mimi DARKO, African Medicines Agency, Kigali, Rwanda
11:00 a.m.
Session 1 - New surveillance and diagnostic tools
Moderators :
Ibrahima Socé FALL, Institut Pasteur of Dakar, Senegal
Dounia CHERKAOUI, ANRS MIE, Paris, France
Dounia CHERKAOUI, ANRS MIE, Paris, France
DIATROPIX: a model for the development and local production of diagnostic tools to strengthen health security in Africa
• Cheikh Tidiane DIAGNE, Institut Pasteur of Dakar, Senegal
• Cheikh Tidiane DIAGNE, Institut Pasteur of Dakar, Senegal
Investigating the animal reservoir of the monkeypox virus using museum specimens
• Antoine GESSAIN, Institut Pasteur, France
Pandemic preparedness to Respiratory Virus X: integrative modelling from first cases to early public health countermeasures
• Mircea SOFONEA, University of Montpellier, Nîmes University Hospital Center, France
12:30 p.m.
Lunch break
ANRS MIE Forum
Discussion space in the Honnorat Room
12:45 p.m.
Start Programme: supporting the next generation of scientists. Meeting with the laureates of the 2025 doctoral grants
• Yazdan YAZDANPANAH, Director of ANRS MIE
• Coline BANCEL, Programme Start Project Manager, ANRS MIE
• Coline BANCEL, Programme Start Project Manager, ANRS MIE
1:00 p.m.
Support for project leaders by the Innovation Committee
• ANRS MIE Innovation Department
1:15 p.m.
No innovation without association: community stakeholders at every stage of research
• Christophe ROUQUETTE, Activities Coordinator, TRT-5 CHV
• Nicolas LORENTE, Head of the Community Research Unit, Coalition PLUS
• Nicolas LORENTE, Head of the Community Research Unit, Coalition PLUS
2:00 p.m.
Tribute to Professor Laurence WEISS
2:15 p.m.
Session 1 (continued) - New surveillance and diagnostic tools
Moderators :
Ibrahima Socé FALL, Institut Pasteur of Dakar, Senegal
Dounia CHERKAOUI, ANRS MIE, Paris, France
Dounia CHERKAOUI, ANRS MIE, Paris, France
Decentralizing molecular diagnostics with synthetic biology
• Margot KARLIKOW, En Carta Diagnostics, Paris, France
• Margot KARLIKOW, En Carta Diagnostics, Paris, France
Non-invasive diagnosis of respiratory infections through the analysis of volatile organic compound and breath signature
• Early career researcher: Delphine PARRAUD, Civil Hospices of Lyon, France
3:00 p.m.
Coffee break
3:45 p.m.
Round table 1 - Translating academic research: opportunities and support
Moderator : Paul DE BREM, science journalist
• Pascale AUGÉ, Inserm Transfert, Paris, France
• Pierre-Olivier FARENQ, National Agency for Medicines and Health Products, Saint-Denis, France
• Jean-Philippe HERBEUVAL, National Centre for Scientific Research, Paris, France
• Joel LELIEVRE, GSK, Madrid, Spain
• Rosalie MAURISSE, Bpifrance, Paris, France
• Pierre-Olivier FARENQ, National Agency for Medicines and Health Products, Saint-Denis, France
• Jean-Philippe HERBEUVAL, National Centre for Scientific Research, Paris, France
• Joel LELIEVRE, GSK, Madrid, Spain
• Rosalie MAURISSE, Bpifrance, Paris, France
5:00 p.m.
Keynote Lectures
Artificial Intelligence agents for accelerating biomedical discoveries
• James ZOU, Stanford University, USA
• James ZOU, Stanford University, USA
5:30 p.m.
Closing Day
• Didier SAMUEL, Chairman and Chief Executive Officer of Inserm, France
6:00 p.m.
Cocktail reception
ANRS MIE Forum
Discussion space in the Honnorat Room
6:00 p.m.
“Translating academic research: opportunities and support”: continuation of the discussions
• With the speakers from Round table #1
6:15 p.m.
The BE READY European Partnership for the French scientific community
• Natalia MARTIN, Head of the Europe Division, ANRS MIE
• Laurent JABOEUF, European Programmes Coordinator, ANRS MIE
• Quentin GADAY, Scientific Programming Officer for Europe, ANRS MIE
• Hervé RAOUL, Deputy Director of ANRS MIE and Delegate for European Affairs
• Laurent JABOEUF, European Programmes Coordinator, ANRS MIE
• Quentin GADAY, Scientific Programming Officer for Europe, ANRS MIE
• Hervé RAOUL, Deputy Director of ANRS MIE and Delegate for European Affairs
8:15 a.m.
Welcome coffee
9:00 a.m.
Opening Day
• Charles-Edouard ESCURAT, Director general of French Health Innovation Agency, General Secretariat for Investment, France
• Isabelle RICHARD, Chair of the ANRS MIE Advisory Board, Director of the EHESP, French School of Public Health, France
• Isabelle RICHARD, Chair of the ANRS MIE Advisory Board, Director of the EHESP, French School of Public Health, France
9:30 a.m.
Keynote Lectures
Novel approaches to vaccine research in HIV: is it translatable to other infectious diseases?
• Glenda GRAY, University of the Witwatersrand, Johannesburg, South Africa
• Glenda GRAY, University of the Witwatersrand, Johannesburg, South Africa
10:00 a.m.
Session 2 - Vaccination in the era of emerging technologies
Moderators :
Éric QUEMENEUR, France Vaccins, Paris, France
Nabila SEDDIKI, French Alternative Energies and Atomic Energy Commission, Fontenay-aux-Roses, France
Nabila SEDDIKI, French Alternative Energies and Atomic Energy Commission, Fontenay-aux-Roses, France
Reverse vaccinology 3.0: the Artificial Intelligence revolution accelerating vaccine development
• Emanuele ANDREANO, Fondazione Biotecnopolo di Siena, Italy
• Emanuele ANDREANO, Fondazione Biotecnopolo di Siena, Italy
10:30 a.m.
Coffee break
11:00 a.m.
Session 2 (continued) - Vaccination in the era of emerging technologies
Moderators :
Éric QUEMENEUR, France Vaccins, Paris, France
Nabila SEDDIKI, French Alternative Energies and Atomic Energy Commission, Fontenay-aux-Roses, France
Nabila SEDDIKI, French Alternative Energies and Atomic Energy Commission, Fontenay-aux-Roses, France
Designing mRNA vaccines using Artificial Intelligence
• Saranya SRIDHAR, Sanofi, London, United Kingdom
• Saranya SRIDHAR, Sanofi, London, United Kingdom
From mucosal immunology to nasal vaccines: a scientific journey
• Mathieu EPARDAUD, Inrae / University of Tours, France
Enhancing self-amplifying mRNA technology activity in mammalian cells
• Early career researcher: Raul Yusef SANCHEZ DAVID, Blizard Institute, Queen Mary University of London, United Kingdom
12:15 a.m.
Lunch break
ANRS MIE Forum
Discussion space in the Honnorat Room
12:30 p.m.
Start Programme: supporting the next generation of scientists. Focus on two networks of young researchers
• Network of Young Social Science Researchers on HIV/AIDS and Sexual Health (RJCSS HIV)
• ANRS MIE Young Basic Research Community Network (AMYB)
• ANRS MIE Young Basic Research Community Network (AMYB)
12:45 p.m.
Training in Clinical Health Research, ANRS MIE – AFRAVIH: feedback, and outlook for 2027
• Alpha DIALLO, Head of the Vigilance Department
• Léa LEVOYER, Pharmacovigilance Officer, ANRS MIE
1:00 p.m.
The ANRS MIE International Network: presentation of partnerships in France, West and Central Africa, South-East Asia and Brazil
• ANRS MIE Strategy & Partnerships Department
1:30 p.m.
Session 3 - Innovative therapeutic approaches
Moderators :
Ana ZARUBICA, Inserm-National Centre for Scientific Research, Marseille, France
Mustapha Si TAHAR, Research Center for Respiratory Diseases, Tours, France
Mustapha Si TAHAR, Research Center for Respiratory Diseases, Tours, France
Human antibody production within the body: application to SARS-CoV2
• Bruno PITARD, Inserm-National Centre for Scientific Research, Nantes, France
• Bruno PITARD, Inserm-National Centre for Scientific Research, Nantes, France
A new TB drug candidate: the story behind the science
• Alain BAULARD, Inserm-Institut Pasteur of Lille, France
• Alain BAULARD, Inserm-Institut Pasteur of Lille, France
Taking away a virus’ superpowers by outsmarting its evolutionary strategies
• Marco VIGNUZZI, A*STAR Infectious Diseases Labs, Singapour
3:00 p.m.
Coffee break
3:45 p.m.
Session 3 (continued) - Innovative therapeutic approaches
Moderators :
Ana ZARUBICA, Inserm-National Centre for Scientific Research, Marseille, France
Mustapha Si TAHAR, Research Center for Respiratory Diseases, Tours, France
Mustapha Si TAHAR, Research Center for Respiratory Diseases, Tours, France
Large-scale biomanufacturing of human mini-organs for infectious disease research
• Edwin ROSADO-OLIVIERI, New York University, USA
• Edwin ROSADO-OLIVIERI, New York University, USA
A host metabolite as a new therapeutic approach against influenza
• Early career researcher: Adeline CEZARD, Centre for the Study of Respiratory Diseases, Tours, France
Harnessing host factors associated with virus induced structures to design antiviral strategies against Orthonairoviruses
• Early career researcher: Solène DENOLLY, Inserm, Lyon Cancer Research Centre, France
4:45 p.m.
Round table 2 - How to ensure global access to new treatments? The example of HIV
Moderator : Paul DE BREM, science journalist
• Ines ALAOUI, Coalition PLUS, Paris, France
• Samia DAKHIA, ViiV Helthcare, London, United Kingdom
• Michel JOLY, Gilead Sciences, Paris, France
• Carmen PEREZ CASAS, Unitaid, Geneva, Suisse
• Ibrahima Socé FALL, Institut Pasteur of Dakar, Senegal
• Mitchell WARREN, AIDS Vaccine Advocacy Coalition, New-York, USA
• Samia DAKHIA, ViiV Helthcare, London, United Kingdom
• Michel JOLY, Gilead Sciences, Paris, France
• Carmen PEREZ CASAS, Unitaid, Geneva, Suisse
• Ibrahima Socé FALL, Institut Pasteur of Dakar, Senegal
• Mitchell WARREN, AIDS Vaccine Advocacy Coalition, New-York, USA
6:00 p.m.
Closing Day2 / Concluding Remarks
• Anne-Claire AMPROU, Ambassador for Global Health, ministry for Europe and Foreign Affairs, France
• Yazdan YAZDANPANAH, Director of ANRS Emerging infectious diseases, France
• Yazdan YAZDANPANAH, Director of ANRS Emerging infectious diseases, France